Medical Devices Startups

Powerbox designs and manufactures power conversion solutions for demanding applications in defense, medical, transportation, and industrial sectors where reliability is critical.

1 investor

Poxel is a clinical-stage biopharmaceutical company developing treatments for chronic metabolic diseases, including metabolic dysfunction-associated steatohepatitis and rare genetic disorders. The company is advancing drug candidates targeting metabolic pathways and has one approved product marketed in Japan.

1 investor

GMP Publications, Inc. provides training, auditing services, and compliance boot camps for companies and consumers in regulated industries including pharmaceuticals, medical devices, biologics, cosmetics, and dietary supplements.

1 investor

PreciPoint develops digital microscopy systems, including a live digital microscope for rapid on-site sample evaluation. Its products serve laboratory and pathology settings.

1 investor

Precise Bio is a regenerative medicine company that develops bio-printed tissues and organs using a 4D bio-fabrication platform, initially focused on ophthalmology including a fabricated human cornea program. It serves patients with unmet medical needs that cannot be met with donor tissue, with facilities in North Carolina, USA and Shoham, Israel.

1 investor

Precision Microbubbles develops the M Sorter, a benchtop device that purifies commercially available microbubble suspensions into uniform-sized populations for scientific and medical applications. The device is designed for researchers and clinicians who require consistent, monodisperse microbubbles without complex synthesis processes.

1 investor

Precision ADM provides metal additive manufacturing services and solutions for industrial applications.

1 investor

PrecisionCare AI develops sensing technology and analytics for physical therapy to provide objective measurement of soft tissue treatment. The platform serves clinicians and health systems seeking to improve therapeutic precision and outcomes at scale.

1 investor

Precision Coating provides surface modification and coating services for medical devices, wires, and instruments. The company serves global healthcare and medical device manufacturers with custom coating, anodizing, and printing solutions for products like guidewires and implants.

1 investor

PrecisionLife uses advanced AI and analytics to identify the biological mechanisms underlying complex chronic diseases, enabling earlier diagnosis and more personalized treatment selection. The company develops diagnostic tests, clinical tools, and insights for pharmaceutical and healthcare partners to improve disease understanding and patient outcomes across multiple therapeutic areas.

1 investor

PrecisionPhage develops computational and laboratory solutions for bacteriophage research to address antimicrobial resistance. The company creates bioinformatics tools and phage-based technologies intended for healthcare and biotech applications globally.

1 investor

PRECISIS develops bioelectronic therapies for neurological conditions, including EASEE, a minimally invasive neurostimulation system implanted under the scalp to treat drug-resistant focal epilepsy without brain surgery. The company targets patients with medication-resistant epilepsy and the medical professionals who treat them.

1 investor

Predicta Med develops a data analytics platform using deep learning to identify at-risk autoimmune disease patients across multiple medical systems, enabling clinicians to intervene earlier and improve diagnostic outcomes.

1 investor

Predicta Biosciences operates a molecular insights platform for blood cancer care, using whole genome sequencing of intact circulating tumor cells from a single blood sample combined with single-cell immune profiling to characterize disease biology and immune response. Its diagnostics serve clinicians, researchers, and pharmaceutical partners working in hematological malignancies such as multiple myeloma.

1 investor

PrediSurge develops AI-powered digital twin technology that converts CT scans into patient-specific models to help clinicians plan and execute cardiovascular interventions, particularly aortic endovascular repairs. The company serves vascular surgeons and medical device manufacturers seeking to enhance surgical precision and patient outcomes through predictive, simulation-based decision support.

1 investor

PreDxion Bio develops rapid diagnostic tests using saliva samples and a scalable semiconductor-based platform, initially targeting SARS-CoV-2 detection for asymptomatic and presymptomatic individuals, with broader applications in monitoring immune response markers in critically ill patients and predicting complications from cell therapies.

1 investor

Smart Human Dynamics develops Pregnancy Coach, a digital health platform that monitors physiological metrics and recommends behaviors to reduce pregnancy complications for expectant mothers. The company focuses on preventing preeclampsia, stillbirth, preterm birth, and other obstetric risks.

1 investor

Pregnostica develops technology and medical devices that detect pregnancy- and childbirth-related pathologies during the first trimester, using patented biomarkers and algorithms to enable early treatment. Its research targets conditions such as gestational diabetes.

1 investor

Prelude Fertility operates a network of partnerships connecting aspiring parents with fertility treatment providers, including donor egg banks, financial bundling services, virtual pharmacy services, and reproductive health supplements.

1 investor

Premark Pharma develops therapeutic candidates for ophthalmologic conditions including blepharitis and dry eye disease. The company is advancing clinical-stage programs through Phase 3 development.

1 investor

Prenosis develops AI-powered precision medicine diagnostics for acute care, built on its Immunix platform and a biobank of clinical data for infection. Its Sepsis ImmunoScore is an FDA-authorized AI diagnostic that integrates biomarkers and clinical data into hospital electronic medical records to diagnose sepsis and predict patient outcomes.

1 investor

A healthcare-focused company spun out from Hamamatsu University School of Medicine that aims to develop disease treatments and save patients' lives through scientific innovation. The company also contributes to disaster preparedness and emergency medical response in the Hamamatsu region.

1 investor

Presentient develops BRAKES, a data science platform that analyzes clinical trial data using automation in secure enclaves to maintain blinding while enabling interim analyses, potentially reducing trial duration by up to 50% and identifying failing trials early.

1 investor

PreView Medical develops AI-powered spectroscopy systems for prostate cancer detection and treatment. The company has created the ClariCore® Biopsy System to improve detection during biopsies and a focal therapy system for precise treatment of prostate cancer.

1 investor